InvestorsHub Logo

DewDiligence

06/29/20 4:16 PM

#544 RE: DewDiligence #517

FDA approves Keytruda monotherapy in 1L-MSI-H/dMMR CRC, converting the 2017 accelerated approval (#msg-131597556) to a full approval:

https://www.prnewswire.com/news-releases/fda-approves-first-line-immunotherapy-for-patients-with-msi-hdmmr-metastatic-colorectal-cancer-301085293.html